Corrigendum to “Impact of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography on Prostate Cancer Salvage Radiotherapy Management: Results from a Prospective Multicenter Randomized Phase 3 Trial (PSMA-SRT NCT03582774)” [Eur Urol. 86(1) (2024) 52–60],European Urology

当前位置： X-MOL 学术 › Eur. Urol. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Corrigendum to “Impact of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography on Prostate Cancer Salvage Radiotherapy Management: Results from a Prospective Multicenter Randomized Phase 3 Trial (PSMA-SRT NCT03582774)” [Eur Urol. 86(1) (2024) 52–60]
European Urology ( IF 25.3 ) Pub Date : 2024-11-09 , DOI: 10.1016/j.eururo.2024.10.022
Wesley R. Armstrong, Amar U. Kishan, Kiara M. Booker, Tristan R. Grogan, David Elashoff, Ethan C. Lam, Kevyn J. Clark, Michael L. Steinberg, Wolfgang P. Fendler, Thomas A. Hope, Nicholas G. Nickols, Johannes Czernin, Jeremie Calais

The authors regret about typological errors in the article found by Feng Qi as published in the letter to the editor of July 25, 2024 in European Urology.

中文翻译：

“前列腺特异性膜抗原正电子发射断层扫描/计算机断层扫描对前列腺癌挽救性放疗管理的影响：前瞻性多中心随机 3 期试验（PSMA-SRT NCT03582774）的结果”的勘误 [Eur Urol. 86（1）（2024） 52–60]

作者对 2024 年 7 月 25 日发表在《欧洲泌尿学》上给编辑的信中发现的冯琦发现的文章中的类型错误表示遗憾。

更新日期：2024-11-09

点击分享查看原文

点击收藏

阅读更多本刊新发论文本刊介绍/投稿指南